Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for advanced NSCLC. Will meta-analysis provide the answer?

T le Chevalier1

  • 1Institut Gustave Roussy, Villejuif, France.

Chest
|May 1, 1996
PubMed
Summary

Chemotherapy offers a survival benefit for non-small cell lung cancer (NSCLC) patients when compared to supportive care alone. Cisplatin-based chemotherapy showed significant advantages in a comprehensive data analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Developments in the treatment of early NSCLC: when to use chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Area of Science:

  • Medical Oncology
  • Clinical Trials
  • Cancer Research

Background:

  • Published meta-analyses suggest chemotherapy improves outcomes in non-small cell lung cancer (NSCLC), but may be subject to publication bias.
  • Previous literature-based reviews might overestimate treatment benefits due to favoring positive results.

Purpose of the Study:

  • To conduct an individual patient data meta-analysis to accurately assess the efficacy of chemotherapy in non-small cell lung cancer (NSCLC).
  • To evaluate the impact of different chemotherapy regimens and patient factors on survival outcomes.

Main Methods:

  • A meta-analysis of individual patient data was performed, incorporating 11 published and unpublished randomized controlled trials.
  • Patient data were analyzed to compare chemotherapy regimens (cisplatin-based, vinca alkaloids/etoposide, alkylating agents) against best supportive care.
  • Outcomes were assessed irrespective of patient demographics, disease stage, histology, or performance status.

Main Results:

  • Cisplatin-based chemotherapy demonstrated a significant survival benefit compared to supportive care alone in non-small cell lung cancer (NSCLC) patients.
  • Vinca alkaloids and etoposide showed a small, non-significant benefit.
  • Alkylating agents provided no discernible survival benefit.

Conclusions:

  • Cisplatin-based chemotherapy is an effective treatment option for improving survival in non-small cell lung cancer (NSCLC).
  • The observed survival benefits are consistent across various patient subgroups.
  • Individual patient data meta-analyses offer a more reliable assessment of treatment efficacy than literature-based reviews.

Related Experiment Videos